SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is actively trending as market participants analyze former President Trump's speech at the World Economic Forum in Davos. His remarks, particularly those concerning Greenland and the broader economic outlook, are sparking intense debate within the community. Discussion centers on whether his bullish pronouncements or controversial international rhetoric will ultimately dictate market sentiment amid geopolitical tensions.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group (DJT) is trending as Donald Trump's remarks at the World Economic Forum captivate audiences, with community attention centered on his controversial proposals for tariffs and persistent calls to acquire Greenland. These statements are fueling polarized debates regarding their potential impact on international relations and market stability, alongside widespread commentary on his public speaking style.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending after its Q4 earnings report, which, despite solid subscriber growth and ad revenue, prompted a significant stock decline due to conservative Q1 guidance and investor concerns over the proposed Warner Bros. Discovery acquisition. The community is sharply divided; bulls view the deep pullback as an oversold opportunity given strong long-term fundamentals and content potential, while bears focus on the acquisition's cost, debt implications, and paused share buybacks as potential headwinds for future profitability.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed is trending following news that its subsidiary, Lucid Diagnostics, was awarded a contract by the U.S. Department of Veterans Affairs for its EsoGuard Esophageal DNA Test. This development has ignited widespread community discussion, with many highlighting the stock's low share float and speculating about a potential short squeeze, drawing parallels to other recent volatile small-cap movements. Community members are actively debating the contract's impact on PAVmed's valuation, especially given its significant ownership stake in Lucid.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending due to widespread market discussion around geopolitical tensions, specifically former President Trump's rhetoric on Greenland and trade policy during his Davos address. The community is actively debating whether perceived softening in his stance will alleviate pressure or if broader concerns over trade relations and central bank policy will continue to influence growth-oriented tech assets.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing heightened investor attention and bullish momentum as multiple analyst upgrades and anticipation of its upcoming earnings report fuel a narrative of a strong turnaround. The community is actively discussing its resilience and upward trajectory, particularly given its performance on down market days, with many highlighting its strategic position in AI and domestic manufacturing capabilities amidst robust demand.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network (BNAI) is a top trending stock after securing a $2.05 million AI licensing partnership in Africa, which includes a pilot program with Nelson Mandela University. The community is intensely focused on the stock's notably low float and high short interest, driving widespread discussion about a potential squeeze. While many anticipate further upside, others express caution, debating the valuation in light of the deal size and raising concerns about potential volatility.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is experiencing intense community discussion, fueled by recent high-grade silver drill results and a broadly bullish sentiment across precious metals markets. Investors are actively debating the company's valuation, weighing its significant resource potential and strategic investor interest against its current pre-production status and capital requirements.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is a major discussion point after announcing it met revised 2025 production targets and increased vehicle deliveries, boosted by the Gravity SUV, alongside news of a robotaxi alliance with Uber and Nuro. While some investors see this as a sign of operational progress, community sentiment remains divided, with concerns over long-term profitability, cash burn, and leadership driving ongoing, intense debate within the challenging EV market.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is actively discussed following positive FDA guidance that sets a path for expanded use of its ANKTIVA treatment for bladder cancer, with the community noting no new trials are required and a resubmission timeline established. Investors are highly engaged, anticipating further global approvals
including for lung cancer
and future catalysts like AI-driven manufacturing, fueling strong conviction amidst persistent short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Myriad Genetics (NASDAQ:MYGN) Downgraded by Zacks Research to Strong Sell

Zacks Research downgraded shares of Myriad Genetics from a "hold" rating to a "strong sell" rating in a research note on Monday...

Myriad Genetics (NASDAQ:MYGN) Stock Price Down 6.5% - Time to Sell?

Myriad Genetics (NASDAQ:MYGN) Trading Down 6.5% - Here's What Happened...

TEM's Collab for Oncology Patient Population Is Gaining Attention

Tempus AI's partnerships with NYU Langone and Northwestern Medicine aim to expand genomic testing and data-driven cancer care.

Myriad Genetics Reports Preliminary Q4 Revenue; Issues 2026 Guidance

(RTTNews) - Myriad Genetics, Inc. (MYGN) said it expects fourth quarter total revenues to be between $207 million and $209 million. Full year 2025 total revenues are projected to be between $822...

Myriad Genetics (NASDAQ:MYGN) Stock Passes Above 200 Day Moving Average - Here's Why

Myriad Genetics (NASDAQ:MYGN) Share Price Passes Above 200 Day Moving Average - Should You Sell...

Should Myriad Genetics Stock Stay in Your Portfolio Right Now?

MYGN shows growth potential from new genetic test launches and a refreshed CCC strategy, but revenue pressure from GeneSight coverage loss remains a drag.

Myriad Genetics (NASDAQ:MYGN) Share Price Passes Above 200-Day Moving Average - Here's Why

Myriad Genetics (NASDAQ:MYGN) Stock Passes Above Two Hundred Day Moving Average - Here's Why...

Myriad Genetics, Inc. $MYGN Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. raised its stake in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 301.2% in the third quarter, according to the company in its most recent disclosure with the...

Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Average Recommendation of "Hold" from Brokerages

Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) has received a consensus rating of "Hold" from the fourteen analysts that are presently covering the firm, Marketbeat Ratings reports. Two...

Myriad Genetics, Inc. $MYGN Stake Reduced by Camber Capital Management LP

Camber Capital Management LP decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 14.9% in the 2nd quarter, according to the company in its most recent filing with...

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$5.66
Prev Close	$5.68
Open	$5.62
Dividend Yield	0.00%
50-Day Moving Average	$6.73
Beta	1.22
Avg. Volume	918,628.73
PE Ratio	-1.31

52-Week High	$15.47
52-Week Low	$3.76
Market Capitalization	$529.45M
EPS (Annual)	-$1.41
Price to Book	1.42
Revenue Per Employee	$310,222.22
Enterprise Value/EBITDA	N/A

MYGN
Myriad Genetics, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MYGN News

MYGNMyriad Genetics, Inc.